Headline
The latest stories from AHA Today.
The Food and Drug Administration released COVID-19 performance data for four more antibody test kits. The results come from the first collaboration between FDA, the National Institute of Health’s National Cancer Institute, Centers for Disease Control and Prevention and Biomedical Advanced Research…
The Department of Health and Human Services released guidance specifying what data laboratories must report to HHS along with their COVID-19 test results, the method for submission, and the data reporting and transmission requirements.
The AHA is sharing new case studies, leadership blogs and tools every day this week to mark Community Health Improvement Week.
The Food and Drug Administration this week released guidance for institutional review boards seeking clarity regarding the key factors and procedures they should consider when reviewing requests by physicians and others for individual patient access to investigational drugs.
Social distancing interventions started earlier in the COVID-19 epidemic appear to delay the epidemic curve while interventions started later appear to flatten it, according to a new study published in the Centers for Disease Control and Prevention’s Emerging Infectious Diseases Journal.
The Centers for Medicare & Medicaid Services recently issued new guidance implementing the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group, established by the Families First Coronavirus Response Act.
The Senate approved by unanimous consent the AHA-supported Paycheck Protection Program Flexibility Act of 2020 (H.R. 7010) to allow more leeway for small business loans during the COVID-19 crisis.
During Community Health Improvement Week, the AHA is sharing stories, resources, tools and leadership blogs that reflect on the importance of community and highlight strong hospital-community partnerships that are helping people live healthier lives.
The Food and Drug Administration recently created an online compendium page of COVID-19 resources for health care professionals.
The Food and Drug Administration authorized the emergency use of two new products designed to respond to the COVID-19 ventilator shortage.